Overactive pathway activity points to metastatic prostate cancer
Measuring the level of activity of a signaling pathway called Hedgehog may differentiate between localized and metastatic prostate cancer, according to research from Johns Hopkins Medical Institute.
Measuring the level of activity of a signaling pathway called Hedgehog may differentiate between localized and metastatic prostate cancer, according to research from Johns Hopkins Medical Institute.
In the Sept. 12 advance online edition of the journal Nature, Johns Hopkins researchers report that only three of 12 localized prostate cancers obtained at surgery had detectable activity in the Hedgehog signaling pathway. By contrast, all 15 samples of metastatic cancer samples they acquired had detectible Hedgehog pathway activity. Hedgehog pathway activity was also 10 to 100 times higher in the metastatic samples than in the localized cancer samples, the study found.
"If we can use Hedgehog activity to predict whether a tumor will metastasize, we will have a great diagnostic tool, but manipulating the Hedgehog signaling pathway may also offer a completely new way to treat metastatic prostate cancer," said David Berman, MD, PhD, of Johns Hopkins.
Malpractice Consult: How likely are you to face a medical malpractice lawsuit?
July 23rd 2024"Although there is a good chance that you will face allegations of medical negligence at some point in your career, it is unlikely that you will ever be found liable by a jury," writes Victoria L. Neikam, Esq.
UK study of AI-based software for prostate cancer detection expands
July 22nd 2024"We will be looking not only at how well this software performs in a busy clinical setting and whether diagnostic accuracy and efficiency improves, but also assessing the experience of clinicians and patients, and looking at the impact on workflow," says Clare Verrill, BM, FRCPath, MMedEd.
